drugset / Trial / NCT06893835
Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline
RandomizedParallel-groupOpen-labelTreatment
Summary
Objective from this study to compare the clinical outcomes and safety between colistin and tigecycline for multi-drug resistant gram negative bacteria.
Timeline
- Start
- 2024-12-01
- Primary completion
- 2025-05-30
- Completion
- 2025-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Colistimethate | Unknown | 2.5 mg/kg | Intravenous |
| Comparator | Colistimethate | Unknown | 5 mg/kg | Intravenous |
| Comparator | Tigecycline | Small molecule | 25 mg | Intravenous |
| Comparator | Tigecycline | Small molecule | 50 mg | Intravenous |